Maximum recovery after knee replacement the MARKER study rationale and protocol

BMC Musculoskeletal Disorders

Volumn 10, Issue 1, 2009, Pages

  Lin, Chung Wei Christine ^a   March, Lyn ^b   Crosbie, Jack ^a   Crawford, Ross ^c   Graves, Stephen ^d   Naylor, Justine ^e   Harmer, Alison ^a   Jan, Stephen ^a   Bennell, Kim ^f   Harris, Ian ^e   Parker, David ^g   Moffet, Helene ^h   Fransen, Marlene ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g Sydney Orthopaedic Research Institute   (Australia)

^h UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; EXERCISE; EXERCISE INTENSITY; FATIGUE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; FUNCTIONAL TRAINING; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOME CARE; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HUMAN; JOINT FUNCTION; KNEE PAIN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT SATISFACTION; PHYSICAL PERFORMANCE; PRIVATE HOSPITAL; PRODUCTIVITY; PUBLIC HOSPITAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGEON; TOTAL KNEE REPLACEMENT; AMBULATORY CARE; COMPARATIVE STUDY; CONVALESCENCE; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; DISABILITY; ECONOMICS; FEMALE; HEALTH CARE COST; KINESIOTHERAPY; KNEE ARTHROPLASTY; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; STANDARD; STATISTICS; TIME; TREATMENT OUTCOME; WALKING DIFFICULTY;

ACTIVITIES OF DAILY LIVING; AGED; AMBULATORY CARE; ARTHROPLASTY, REPLACEMENT, KNEE; AUSTRALIA; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; DISABILITY EVALUATION; EXERCISE THERAPY; FEMALE; HEALTH CARE COSTS; HOME NURSING; HUMANS; MALE; MIDDLE AGED; MOBILITY LIMITATION; OUTCOME ASSESSMENT (HEALTH CARE); RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 68349114770     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-10-69     Document Type: Article

References (66)

1. Australian Orthopaedic Association National Joint Replacement Registry, Annual Report Adelaide: Australian Orthopaedic Association 2008
2. National Joint Registry for England and Wales 4th Annual Report. http://www.njrcentre.org.uk
3. Changing incidence of primary total hip arthroplasty and total knee arthroplasty for primary osteoarthritis. VM Wells TC Hearn KA McCaul SM Anderton AE Wigg SE Graves, J Arthroplasty 2002 17 267 273 10.1054/arth.2002.30414 11938500 (Pubitemid 34289998)
4. New Zealand National Joint Register. http://www.cdhb.govt.nz/NJR/
5. The Swedish Knee Arthroplasty Register, Annual Report Lund: Wallin & Dalholm AB 2008
6. Canadian Institute for Health Information, Canadian Joint Replacement Registry (CJRR) 2007 annual report hip and knee replacements in Canada Ottawa: CIHI 2008
7. The Norwegian Arthroplasty Register. http://www.haukeland.no/nrl/eng/ default.htm
8. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. T Dixon M Shaw S Ebrahim P Dieppe, Ann Rheum Dis 2004 63 825 830 15194578 10.1136/ard.2003.012724 (Pubitemid 38850454)
9. The orthopaedic approach to managing osteoarthritis of the knee. S Gidwani A Fairbank, BMJ 2004 329 1220 1224 15550426 10.1136/bmj.329.7476.1220
10. Revision rates after primary hip and knee replacement in England between 2003 and 2006. N Sibanda LP Copley JD Lewsey M Borroff P Gregg AJ MacGregor M Pickford M Porter K Tucker JH van der Meulen, PLoS Med 2008 5 e179 18767900 10.1371/journal.pmed.0050179
11. Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA. B Fautrel P Hilliquin S Rozenberg FA Allaert P Coste A Leclerc M Rossignol, Joint Bone Spine 2005 72 235 240 10.1016/j.jbspin.2004. 08.009 15850995 (Pubitemid 40591764)
12. Isometric muscle force measurement for clinicians treating patients with osteoarthritis of the knee. M Fransen J Crosbie J Edmonds, Arthritis Rheum 2003 49 29 35 10.1002/art.10923 12579591
13. Cardiovascular fitness and health in patients with end-stage osteoarthritis. EF Philbin GD Groff MD Ries TE Miller, Arthritis Rheum 1995 38 799 805 10.1002/art.1780380613 7779123
14. Patient quality of life during the 12 months following joint replacement surgery. JD Fitzgerald EJ Orav TH Lee ER Marcantonio R Poss L Goldman CM Mangione, Arthritis Rheum 2004 51 100 109 10.1002/art.20090 14872462
15. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. F Salaffi M Carotti A Stancati W Grassi, Aging Clin Exp Res 2005 17 255 263 16285189 (Pubitemid 46190142)
16. Short-term recovery from hip and knee arthroplasty. H Aarons G Hall S Hughes P Salmon, J Bone Joint Surg Br 1996 78 555 558 8682819
17. Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty. DM Kennedy PW Stratford J Wessel JD Gollish D Penney, BMC Musculoskelet Disord 2005 6 3 15679884 10.1186/1471-2474-6-3 (Pubitemid 40300841)
18. Locomotor deficits before and two months after knee arthroplasty. D Ouellet H Moffet, Arthritis Rheum 2002 47 484 493 10.1002/art.10652 12382296 (Pubitemid 35291369)
19. Quadriceps strength and volitional activation before and after total knee arthroplasty for osteoarthritis. JE Stevens RL Mizner L Snyder-Mackler, J Orthop Res 2003 21 775 779 10.1016/S0736-0266(03)00052-4 12919862 (Pubitemid 37045553)
20. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. PR Fortin JR Penrod AE Clarke Y St-Pierre L Joseph P Belisle MH Liang D Ferland CB Phillips N Mahomed, Arthritis Rheum 2002 46 33273330
21. A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. CJ Bachmeier LM March MJ Cross HM Lapsley KL Tribe BG Courtenay PM Brooks, Osteoarthritis Cartilage 2001 9 137 146 10.1053/joca.2000.0369 11330253 (Pubitemid 32229263)
22. Recovery from hip and knee arthroplasty: patients' perspective on pain, function, quality of life, and well-being up to 6 months postoperatively. P Salmon GM Hall D Peerbhoy A Shenkin C Parker, Arch Phys Med Rehabil 2001 82 360 366 10.1053/apmr.2001.21522 11245759 (Pubitemid 32199568)
23. Health-related quality of life in total hip and total knee arthroplasty. O Ethgen O Bruyere F Richy C Dardennes JY Reginster, J Bone Joint Surg Am 2004 86 963 974 15118039
24. Predicting total knee replacement pain. A prospective, observational study. VA Brander SD Stulberg AD Adams RN Harden S Bruehl SP Stanos T Houle, Clin Orthop Relat Res 2003 416 34 36 10.1097/01.blo.0000092983.12414.e9
25. Muscle strength after successful total knee replacement: a 6- to 13-year followup. C-H Huang C-K Cheng Y-T Lee K-S Lee, Clin Orthop Relat Res 1996 328 147 154 10.1097/00003086-199607000-00023 8653948
26. Knee strength after total knee arthroplasty. M Silva EF Shepherd WO Jackson JA Pratt CD McClung TP Schamalzried, J Arthroplasty 2003 18 605 611 10.1016/S0883-5403(03)00191-8 12934213 (Pubitemid 37040356)
27. Physical impairments and functional limitations: a comparison of individuals 1 year after total knee arthroplasty with control subjects. M Walsh LJ Woodhouse SG Thomas E Finch, Phys Ther 1998 78 248 258 9520970
28. Higher cumulative revision rate of knee arthroplasties in younger patients with osteoarthritis. OLA Harrysson O Robertsson JF Nayfeh, Clin Orthop Relat Res 2004 421 162 168 10.1097/01.blo.0000127115.05754.ce 15123942
29. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. PL Santaguida GA Hawker PL Hudak R Glazier NN Mahomed HJ Kreder PC Coyte JG Wright, Can J Surg 2008 51 428 436 19057730
30. Status of physiotherapy rehabilitation after total knee replacement in Australia. J Naylor A Harmer M Fransen J Crosbie L Innes, Physiother Res Int 2006 11 35 47 10.1002/pri.40 16594314
31. Does a standard outpatient physiotherapy regime improve the range of knee motion after primary total knee arthroplasty? BJ Mockford NW Thompson P Humphreys DE Beverland, J Arthroplasty 2008 23 8 1110 1114 10.1016/j.arth.2007. 08.023 18534481
32. No need for outpatient physiotherapy following total knee arthroplasty A randomized trial of 120 patients. RA Rajan Y Pack H Jackson C Gillies R Asirvatham, Acta Orthop Scand 2004 75 71 73 10.1080/00016470410001708140 15022811 (Pubitemid 38264928)
33. Comparison of clinic- and home-based rehabilitation programs after total knee arthroplasty. JF Kramer M Speechley R Bourne C Rorabeck M Vaz, Clin Orthop Relat Res 2003 410 225 234 10.1097/01.blo.0000063600.67412.11 12771834
34. Costs and effectiveness of pre- and post-operative home physiotherapy for total knee replacement: randomized controlled trial. C Mitchell J Walker S Walters AB Morgan T Binns N Mathers, J Eval Clin Pract 2005 11 283 292 10.1111/j.1365-2753.2005.00535.x 15869558 (Pubitemid 40755688)
35. Effectiveness of intensive rehabilitation on functional ability and quality of life after first total knee arthroplasty: A single-blind randomized controlled trial. H Moffet JP Collet SH Shapiro G Paradis F Marquis L Roy, Arch Phys Med Rehabil 2004 85 546 556 10.1016/j.apmr.2003.08.080 15083429 (Pubitemid 38881042)
36. Perceived exertion as an indicator of somatic stress. G Borg, Scand J Rehabil Med 1970 2 92 98 5523831
37. Randomized trials to modify patients' preoperative expectations of hip and knee arthroplasties. CA Mancuso S Graziano LM Briskie MGE Peterson PM Pellicei EA Salvati TP Sculco, Clin Orthop Relat Res 2008 466 424 431 18196427 10.1007/s11999-007-0052-z (Pubitemid 351912900)
38. Patients' expectations of knee surgery. CA Mancuso TP Sculco TL Wickiewicz EC Jones L Robbins RF Warren P Williams-Russo, J Bone Joint Surg Am 2001 83 1005 1012 10.1302/0301-620X.83B7.12105 11451969
39. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. N Bellamy WW Buchanan CH Goldsmith J Campbell LW Stitt, J Rheumatol 1988 15 1833 1840 3068365
40. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. N Bellamy, J Rheumatol 2002 29 2473 2476 12465137
41. Measures of adult lower extremity function. JC Rogers JJ Irrgang, Arthritis Rheum 2003 49 S67 S84 10.1002/art.11401
42. Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. A Escobar JM Quintana A Bilbao I Arstegui I Lafuente I Vidaurreta, Osteoarthritis Cartilage 2007 15 273 280 10.1016/j.joca.2006.09.001 17052924 (Pubitemid 46249668)
43. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. JE Brazier R Harper J Munro SJ Walters ML Snaith, Rheumatology (Oxford) 1999 38 870 877 10.1093/rheumatology/38.9.870 10515649 (Pubitemid 29507370)
44. Appropriate questionnaires for knee arthroplasty Results of a survey of 3600 patients from the Swedish Knee Arthroplasty Registry. MJ Dunbar O Robertsson L Ryd L Lidgren, J Bone Joint Surg Br 2001 83 339 344 10.1302/0301-620X.83B3.11134 11341416
45. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. T Pham D van der Heijde RD Altman JJ Anderson N Bellamy M Hochberg L Simon V Strand T Woodworth M Dougados, Osteoarthritis Cartilage 2004 12 389 399 10.1016/j.joca.2004.02.001 15094138 (Pubitemid 38594267)
46. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. J Ware Jr M Kosinski SD Keller, Med Care 1996 34 220 233 10.1097/00005650-199603000-00003 8628042
47. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. B Gandek JE Ware NK Aaronson G Apolone JB Bjorner JE Brazier M Bullinger S Kaasa A Leplege L Prieto, J Clin Epidemiol 1998 51 1171 1178 10.1016/S0895-4356(98)00109-7 9817135 (Pubitemid 28527173)
48. Designing choice experiments with many attributes. An application to setting priorities for orthopaedic waiting lists. J Witt A Scott RH Osborne, Health Econ 2008 17990287
49. Clinically relevant priority ranking for hip and knee joint replacement surgery (JRS): The validation and scaling of the Multi-attribute Arthritis Priority Tool (MAPT) against WOMAC, Oxford hip/knee, SF36, AQoL, EQ-5D and HADS. RH Osborne K Haynes P Chubb D Robbins R de Steiger A Scott P Dieppe P Fayers I Wicks C Brand, Health Outcomes Conference: Managing Health and Disease in Today's Society (12th Annual National Conference). Canberra, Australia 2006
50. Cohort profile: The 45 and up study. E Banks S Redman L Jorm B Armstrong A Bauman J Beard V Beral J Byles S Corbett R Cumming, Int J Epidemiol 2008 37 941 947 17881411 10.1093/ije/dym184
51. T Armstrong A Bauman J Davies, Physical activity patterns of Australian adults. Results of the 1999 National Physical Activity Survey Canberra: Australian Institute of Health and Welfare 2000
52. The prevalence and meaning of fatigue in rheumatic disease. F Wolfe DJ Hawley K Wilson, J Rheumatol 1996 23 1407 1417 8856621
53. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/
54. Development of a patient-reported measure of function of the knee. JJ Irrgang L Snyder-Mackler RS Wainner FH Fu CD Harner, J Bone Joint Surg Am 1998 80 8 1132 1145 9730122
55. Reliability of performance-based measures in people awaiting joint replacement surgery of the hip or knee. S Gill H McBurney, Physiother Res Int 2008 13 141 152 10.1002/pri.411 18697226
56. CC Norkin DJ White, Measurement of a joint motion: a guide to goniometry Philadelphia: FA Davis C 3 2003
57. Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults? JF Bean DK Kiely S LaRose J Alian WR Frontera, Arch Phys Med Rehabil 2007 88 604 609 10.1016/j.apmr.2007.02.004 17466729 (Pubitemid 46627537)
58. A review of methods to measure health-related productivity loss. S Mattke A Balakrishnan G Bergamo SJ Newberry, Am J Manag Care 2007 13 4 211 217 17408341
59. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. M Prasad P Wahlqvist R Shikiar YC Shih, Pharmacoeconomics 2004 22 225 244 10.2165/00019053-200422040- 00002 14974873 (Pubitemid 38393392)
60. A review of health-related workplace productivity loss instruments. JH Lofland L Pizzi KD Frick, Pharmacoeconomics 2004 22 165 184 10.2165/00019053- 200422030-00003 14871164 (Pubitemid 38333649)
61. Determining the sample size in a clinical trial. A Kirby V Gebski AC Keech, Med J Aust 2002 177 256 257 12197821
62. The estimation of a preference-based measure of health from the SF-12. JE Brazier J Roberts, Med Care 2004 42 851 859 10.1097/01.mlr.0000135827.18610.0d 15319610
63. Statistics notes. Treatment allocation in controlled trials: why randomise? DG Altman JM Bland, BMJ 1999 318 7192 1209 10221955
64. A review of blinding in randomized controlled trials found results inconsistent and questionable. I Boutron C Estellat P Ravaud, J Clin Epidemiol 2005 58 1220 1226 10.1016/j.jclinepi.2005.04.006 16291465 (Pubitemid 41608537)
65. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. KF Schulz I Chalmers RJ Hayes DG Altman, JAMA 1995 273 408 412 10.1001/jama.273.5.408 7823387
66. Blinding in randomised trials: hiding who got what. KF Schulz DA Grimes, Lancet 2002 359 696 700 10.1016/S0140-6736(02)07816-9 11879884 (Pubitemid 34203775)